Previous 10 | Next 10 |
Well, probably not all the chips, but taking home most of them is certainly possible. Cathie Wood of ARK investment Management has described Invitae (NYSE: NVTA) as operating in a "winner-take-most" market, and identified Invitae as one of the most under-appreciated companies in her...
The last few months have been especially tough for some healthcare stocks. Teladoc Health (NYSE: TDOC) and Invitae (NYSE: NVTA) are close to 50% off their highs. GoodRx Holdings (NASDAQ: GDRX) is down more than 40% from its peak earlier this year. What should investo...
PacBio saw strong system placements in the first quarter, including multiple multi-system orders, multiple new customers, and orders for COVID-19 surveillance. The key for PacBio remains driving down the cost of the technology; long-read sequencing can already do many things that shor...
Germline genetic testing can benefit all cancer patients as a routine practice in cancer care -- New data to be presented at 2021 ASCO Annual Meeting highlight need for increased germline testing in all cancer patients regardless of medical policy -- PR Newswire SA...
Invitae to Present at the William Blair 41st Annual Growth Stock Conference PR Newswire SAN FRANCISCO , May 20, 2021 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that members of its management team ...
Invitae (NYSE: NVTA) recently reported impressive revenue growth with its first-quarter results. However, the medical genetics company still missed analysts' bottom-line estimates. In this Motley Fool Live video recorded on May 5 , Motley Fool contributors Keith Speights and...
Invitae 's (NYSE: NVTA) winning ways in 2020 have gone by the wayside so far in 2021. Shares of the medical genetics company are down more than 25% year to date. The company announced its first-quarter results after the market closed Tuesday. Invitae's downtrend appears likely t...
The following slide deck was published by Invitae Corporation in conjunction with their 2021 Q1 earnings call. For further details see: Invitae Corporation 2021 Q1 - Results - Earnings Call Presentation
Image source: The Motley Fool. Invitae (NYSE: NVTA) Q1 2021 Earnings Call May 04, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Invitae (NVTA) Q1 2021 Earnings Call Transcript
Invitae Corporation (NVTA) Q1 2021 Earnings Conference Call May 4, 2021 04:30 pm ET Company Participants Laura D'Angelo - Head, Investor Relations Sean George - Chief Executive Officer and Co-Founder Shelly Guyer - Chief Financial Officer Conference Call Participants Tycho Peterson - JP Morga...
News, Short Squeeze, Breakout and More Instantly...
Labcorp Announces Winning Bid for Select Assets of Invitae PR Newswire Advances Labcorp strategy to launch and scale specialty testing in areas such as oncology and rare diseases Transaction requires court approval, with confirmation expected on May 6, 2024 ...
Invitae Enters into Agreement with Labcorp for Sale of Business PR Newswire – Labcorp Selected as Winning Bidder in Court-Supervised Sale Process, Subject to Court and Regulatory Approvals – – $239 Million Cash Bid Includes Acquisition of Substantial...
Invitae Unveils New Research for Breast Cancer Patients with Variants of Uncertain Significance PR Newswire – Study findings to be presented at the 2024 American Society of Breast Surgeons Annual Meeting – SAN FRANCISCO , April 11, 2024 /PRNewsw...